JOSE MANUEL
VALDIVIELSO REVILLA
CON
![Foto de JOSE MANUEL](/img/nophoto.png)
![Foto de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas](/img/noimage_org.png)
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (22)
2024
-
Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort
Sleep Medicine, Vol. 116, pp. 19-26
-
Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus
International Journal of Molecular Sciences, Vol. 25, Núm. 5
2023
-
Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study
Atherosclerosis, Vol. 375, pp. 75-83
-
Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project
Nutrients, Vol. 15, Núm. 1
-
Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort
Atherosclerosis, Vol. 380
2022
-
Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study
Frontiers in Cardiovascular Medicine, Vol. 9
-
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
eBioMedicine, Vol. 76
2021
-
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients
Clinical Kidney Journal, Vol. 14, Núm. 12, pp. 2591-2599
-
Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort
Nutrients, Vol. 13, Núm. 3, pp. 1-15
-
Interleukin-17A: Potential mediator and therapeutic target in hypertension
Nefrologia
-
Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study
Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054
2020
-
IL‐17A as a potential therapeutic target for patients on peritoneal dialysis
Biomolecules, Vol. 10, Núm. 10, pp. 1-36
-
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease
Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 2026-2042
2019
-
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 619-630
-
Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project
Cardiovascular Diabetology, Vol. 18, Núm. 1
-
Lung function measurements in the prediabetes stage: data from the ILERVAS Project
Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012
-
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
Cardiovascular Diabetology, Vol. 18, Núm. 1
-
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project
Diabetes and Metabolism
2018
-
Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
Atherosclerosis, Vol. 270, pp. 13-20
-
Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes
Atherosclerosis, Vol. 276, pp. 50-57